Show Summary Details
Page of

(p. 275) Pharmacological Treatment of Pediatric Irritability 

(p. 275) Pharmacological Treatment of Pediatric Irritability
Chapter:
(p. 275) Pharmacological Treatment of Pediatric Irritability
Author(s):

Daniel P. Dickstein

, and Rachel E. Christensen

DOI:
10.1093/med-psych/9780190846800.003.0014
Page of

date: 25 May 2019

Irritability is among the most common and impairing mental health issues affecting children today, with research showing that the consequences of irritability last into adulthood. Advancing how we treat irritability, including with medications, thus should be a top public health priority, germane to all those working with children and adults, and not just restricted to mental health settings. In this chapter, the authors review general principles of using medication to treat irritability in children. Then, they provide the latest information about the pharmacological treatment of irritability. In doing so, they draw on published studies of disorders involving irritability, including bipolar disorder (BD), unipolar major depressive disorder (MDD), attention deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), intermittent explosive disorder (IED), and autism spectrum disorder (ASD). While there is ample room for innovative ways to assess and treat irritability in children, at present, clinicians should carefully assess the child, develop a working hypothesis for what disorder(s) involving irritability are present, use evidence-based treatments to address those problems, and then reassess for improvement, worsening, side effects, or how these longitudinal data shapes working diagnoses.

Access to the complete content on Oxford Clinical Psychology requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.